drugset / Trial / NCT00002704

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

NCT00002704

Phase 2 Completed 156 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase II trial to study the effectiveness of radiation therapy following chemotherapy in treating children with CNS relapse from acute lymphoblastic leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with radiation therapy may kill more cancer cells.

Timeline

Start
1996-01
Primary completion
2004-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytarabine Small molecule Intrathecal
Subject Thiotepa Other / unclassified
Background 2-MERCAPTOETHANESULFONIC ACID Small molecule
Background Cyclophosphamide Other / unclassified
Background Daunorubicin Small molecule
Background Dexamethasone Small molecule
Background Etoposide Small molecule
Background Hydrocortisone Other / unclassified
Background Leucovorin Small molecule
Background MERCAPTOPURINE ANHYDROUS Small molecule
Background Methotrexate Small molecule
Background Vincristine Small molecule
Background asparaginase Protein / enzyme biologic
Background filgrastim Protein / enzyme biologic

Indications